Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 52Lung Neoplasms 11Breast Neoplasms 11Head and Neck Neoplasms 8Neoplasms 5Neoplasm Metastasis 4NSCLC 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Colorectal Neoplasms 3Carcinoma 3Brain Neoplasms 3Respiratory Tract Diseases 2Neoplasms, Squamous Cell 2Carcinoma, Squamous Cell 2Adenocarcinoma of Lung 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1Small Cell Lung Carcinoma 1Respiratory Tract Neoplasms 1Pancreatic Neoplasms 1Non-Metastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma 1Lung Diseases 1

Interventions

Carboplatin 71Etoposide 63Topotecan 42Cisplatin 38pembrolizumab 30atezolizumab 26durvalumab 22Paclitaxel 16Nivolumab 14PM 01183 13rovalpituzumab tesirine 11Pemetrexed 11amrubicin 9Ipilimumab 9Injections 9Irinotecan 8AMG 757 8trilaciclib 7etoposide phosphate 6EC regimen 6Drug Therapy 6Docetaxel 6Bevacizumab 6tremelimumab 5MLN 8237 5Gemcitabine 5130-nm albumin-bound paclitaxel 5olaparib 4chiauranib 4budigalimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Small Cell Lung Carcinoma × Gefitinib × Clear all
NCT00298688 2008-06-12

A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer

AstraZeneca

Phase 2 Completed
56 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡